
    
      This is a single-arm, prospective, multicenter, non-blinded clinical trial. Study data will
      be summarized and submitted to the FDA in a premarket notification once all treated subjects
      have completed the 3 month visit. Longer term followup is being performed for publication
      purposes.

      Patients diagnosed with incompetent Perforator Veins (IPV's) and meet all inclusion and none
      of the exclusion criteria will be eligible for this study.
    
  